Related Research Articles
Genetic engineering, also called genetic modification or genetic manipulation, is the modification and manipulation of an organism's genes using technology. It is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to produce improved or novel organisms.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.
BioMed Central (BMC) is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. All its journals are published online only. BioMed Central describes itself as the first and largest open access science publisher. It was founded in 2000 and has been owned by Springer, now Springer Nature, since 2008.
The National Human Genome Research Institute (NHGRI) is an institute of the National Institutes of Health, located in Bethesda, Maryland.
Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies. The company was headquartered in Redwood City, CA. It dissolved in 2013. The Maxygen legacy was revived in 2018 with a focus on Directed Evolution of Proteins using Molecular Breeding. Maxygen LLC is currently headquartered in Sunnyvale, CA.
The Journal of Life Sciences is a full-color bimonthly American magazine and daily website published in San Francisco since May 2007. Owned by Burrill & Company and the California Healthcare Institute, TJOLS reports on how developments in the life sciences affect society, business, and policy.
The Journal of Alternative and Complementary Medicine is a monthly peer-reviewed medical journal covering alternative medicine published by Mary Ann Liebert. It was established in 1995 and is the official journal of the Society for Acupuncture Research. The editor-in-chief is John Weeks, who succeeded the founding editor, Kim A. Jobst.
DNA and Cell Biology is a scientific journal published by Mary Ann Liebert, Inc., and covers topics related to DNA and cell biology, such as:
Kyowa Kirin Co., Ltd. is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index.
The American Thyroid Association (ATA) is a professional organization of over 1700 medical specialists devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health. The ATA publishes the journals Clinical Thyroidology for the Public and Signal. The peer-reviewed journals Thyroid, Clinical Thyroidology and VideoEndocrinology are published through Mary Ann Liebert, Inc., publishers.
The Journal of Neurotrauma is a monthly peer-reviewed medical journal covering research on neurotraumas. It is an official journal of the National Neurotrauma Society and the International Neurotrauma Society. The journal was established in 1984 and is published by Mary Ann Liebert, Inc. The editor-in-chief is David L. Brody, MD, PhD.
Genetic Testing and Molecular Biomarkers is a monthly peer reviewed scientific journal published by Mary Ann Liebert, Inc. The editor-in-chief is Garth Ehrlichs. The journal covers genetic testing research along with associated ethical, legal, social, and economic issues. Related genetic testing coverage includes risk assessment, genetic counseling, carrier detection, novel instrumentation, and cytogenetics. It is the official journal of Genetic Alliance.
The Journal of Women's Health is a monthly peer-reviewed healthcare journal focusing on women's health care, including advancements in diagnostic procedures, therapeutic protocols for the management of diseases, and research in gender-based biology that impacts patient care and treatment. The journal was established in 1992 and is published by Mary Ann Liebert, Inc. The editor-in-chief is Susan G. Kornstein. It is the official journal of the Academy of Women's Health and the American Medical Women's Association.
Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Intellia's ex vivo programs use CRISPR to create the therapy by using engineered human cells to treat cancer and autoimmune diseases.
OMICS: A Journal of Integrative Biology is a peer-reviewed scientific journal of omics and integrative biology published by Mary Ann Liebert. The journal was founded in 1995 as Genome Science and Technology, changing its name to Microbial & Comparative Genomics in 1997, eventually acquiring its current title in 2004. The journal is now edited by Vural Özdemir. Since 2008 the journal has been published online only.
The He Jiankui affair is a scientific and bioethical controversy concerning the use of genome editing following its first use on humans by Chinese scientist He Jiankui, who edited the genomes of human embryos in 2018. He became widely known on 26 November 2018 after he announced that he had created the first human genetically edited babies. He was listed in Time magazine's 100 most influential people of 2019. The affair led to ethical and legal controversies, resulting in the indictment of He and two of his collaborators, Zhang Renli and Qin Jinzhou. He eventually received widespread international condemnation.
The CRISPR Journal is a peer-reviewed scientific journal published every three months by Mary Ann Liebert. It covers research on all aspects of CRISPR research, including its uses in synthetic biology and genome editing.
Herald Scholarly Open Access is a publisher of various academic journals. It has a postal address in Herndon, Virginia, United States, but is actually based in Hyderabad, India. Herald Scholarly Open Access has been included on Beall's List of potential predatory open-access publishers, and has faced other criticisms of its publishing practices.
References
- 1 2 3 4 5 6 7 8 9 10 Worley, Dwight R. (23 July 2000). "Genetic Genius - Part 1". Business. The Journal News. White Plains, New York: Gannett. pp. 1, 2–D. Retrieved 31 July 2018– via Newspapers.com.
- ↑ McElroy, Emily; Kubilius, Ramune (2003). "An Interview with Mary Ann Liebert and Tom Mulak" (PDF). Serials Review. 29 (2): 137–143. doi:10.1016/S0098-7913(03)00033-9. S2CID 62532552. Archived from the original (PDF) on 17 March 2006.
- 1 2 "Company Overview of Mary Ann Liebert, Inc". www.bloomberg.com. Retrieved 2018-08-01.
- ↑ Lancaster, Hal (6 August 1995). "Some people are born to be entrepreneurs". Wisconsin State Journal (Reprint from Wall Street Journal). Madison, Wisconsin. p. 1H. Retrieved July 31, 2018– via Newspapers.com.
- ↑ Liebert, Mary Ann. "Genetic Genius - Part 2". Business. White Plains, New York: Gannett. Retrieved 2024-02-24– via Newspapers.com.
- ↑ "Publication List A - Z". Mary Ann Liebert.
- ↑ "Mary Ann Liebert, Inc. | Home". Liebertpub.com. Retrieved 2023-10-02.
- ↑ "The CRISPR Journal, a new peer-reviewed publication launching in 2018". EurekAlert!. Retrieved 2018-03-04.
